NCT06561126Recruiting

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D]

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D]: Cluster Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 2 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This project aims to adapt, implement, and evaluate Participatory Learning and Action (PLA) based intervention in rural areas of KPK, Pakistan which includes Peshawar and Swabi for TIIDM prevention and control. The pivotal components of this approach include adapting, implementing, and evaluating the PLA-based intervention for the prevention and control of Type II diabetes. These components will be tailored to meet the specific needs of two different settings in Peshawar and Swabi, Pakistan. Type II Diabetes Mellitus (TIIDM) is considered the fastest-growing health emergency, affecting 537 million adults worldwide. Global projections for the year 2045 suggest that a 12.2% rise in TIIDM is anticipated with an additional 11.4% rise for intermediate hyperglycemia (IHG) \[1\]. Around 80% of people with TIIDM reside in low-and middle-income countries (LMICs), exhausting the already burdened healthcare system \[2\]. The intervention "Community groups or mobile phone messaging to prevent and control type 2 diabetes and intermediate hyperglycemia in Bangladesh (DMagic)" has been tested and found effective in the rural context of Bangladesh \[1-3\]. A full trial will be conducted in the rural areas of Peshawar and Swabi, Pakistan. It is anticipated that with the use of evidence-based approaches, best practices, and meaningful community participation, PLA is expected to enhance social and behavioural determinants of health and subsequent outcomes. This will further pave the way for the control of other NCDs through a similar focused approach.

Status (registry): Recruiting
Study type: Interventional
Enrollment: 12744 (estimated)
First submitted: 7 Aug 2024
Start date: 1 May 2025
Primary completion date: 30 May 2026
Lead sponsor: Khyber Medical University Peshawar
Diseases: Type 2 diabetes
NCT number: NCT06561126

What you commit to

Study type: Interventional
Planned participants: 12744
From 1 May 2025 to the primary completion date, 30 May 2026
1 site in 1 country
Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

Participants with severe health conditions that may hinder their active involvement in the study.
Individuals with a history of non-compliance with medical interventions or research protocols

Age

Individuals below the age of 20 years.

Other

Individuals unwilling to provide consent for participation.

Who the study is looking for

Individuals aged 20 years and above.
Participants residing in the rural areas of Peshawar and Swabi, Pakistan.
Individuals willing to participate in the study and provide consent.
Both individuals with normoglycemia, intermediate hyperglycemia, and diabetes are encouraged to participate.
Participants who can attend the scheduled meetings and interventions as per the study protocol.

Age in the registry: 20 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

Site	City	Country	Site status
Khyber Medical University Peshawar Coordinator of this site? Confirm its status	Peshawar	Pakistan	Recruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.